cellular stories
Biotech leadership

Help investors and partners understand why your program deserves a closer look.

Build an investor and partner communication program around your treatment’s differentiation, supporting evidence and next development milestone. We develop the scientific narrative, video, interactive resource, and scientific report and literature review with two publication-quality figures so your team has a consistent explanation for introductions, meetings and diligence.

Daraxonrasib film screenshot labeling RAS, daraxonrasib and cyclophilin A in the three-component complexWatch the RAS example ↗
Daraxonrasib · Explaining a complex binding arrangement visually

Give the science a clear place in the investment or partnering case.

Define the questions investors and partners need answered, then connect the mechanism and evidence to the development plan. Give them a concise introduction before the meeting, an interactive resource for diligence and figures for the deck. This is a communication program with its own business brief, separate from patient or physician education.

Fundraising

Connect the scientific rationale and available evidence to the next development milestone and the work financing would support.

Partnering

Help potential partners assess the mechanism, differentiation and open questions before a deeper diligence discussion.

After the meeting

Give recipients a clear resource they can revisit and share with colleagues evaluating the program.

The program materials

A scientific video, interactive website, and scientific report and literature review.

A typical program combines these outputs with an audience-needs brief, objectives, a sourced script and storyboard, and agreed scientific review. The video is roughly 3 minutes. The report includes a focused literature review of the mechanism, clinical evidence and open questions, with two publication-quality figures. Audience-specific versions and a simple evaluation component are agreed in the scope.

Daraxonrasib, cyclophilin A and RAS labeled in a frame from the scientific filmWatch the scientific film ↗01 · Scientific video

Introduce the treatment before the conversation

Introduce the clinical problem, mechanism and supporting evidence before an investor or partnering meeting.

Current T-DM1 interactive website screenshot with Chapters, Sources, Inspect and progress controlsTry the T-DM1 interactive example ↗02 · Interactive website

Give people a resource to return to

Give recipients a resource to explore the science and sources at their own pace after the meeting.

03 · Scientific report and literature review

Understand the evidence and reuse the figures

Receive a focused, referenced scientific report and literature review covering the mechanism, clinical findings and open questions, including two publication-quality figures. Reuse those figures in decks and educational resources, with captions, references and editable SVG, vector PDF and PNG exports. The examples above show the figure format, not a complete report.

Independent educational demonstrations, not commissioned client work or manufacturer endorsements. Existing example lengths vary. Program scope and responsibilities are agreed before production.

Scientific review

Show what is known and what the next milestone would establish.

We agree on the audience, communication objectives and evidence with your team, then review the narrative and visuals with your designated experts. The brief separates hypotheses, laboratory findings and clinical results. Your team provides the development plan and milestone context, including the questions the next study would answer.

From the business brief to a reviewed communication program

  1. Define the audience and objectives

    Agree on the questions to answer, evidence, intended use, deadline and program scope.

  2. Plan, review and build

    Develop the sourced script and storyboard with your designated reviewers, then produce the film, website, scientific report and literature review with two figures.

  3. Deliver and assess

    Adapt the materials for agreed meeting and diligence uses. Scope audience feedback or engagement reporting where useful.

Investor introductions, fundraising execution and external distribution are separate from content development.

Scope a communication program for your next milestone

Tell us about the treatment, investor or partner audience and financing or meeting timeline. We will scope the scientific narrative, formats and review process around the questions they need answered.

Discuss your communication needs ↗

James Baker · Founder · james@cellularstories.com